| Human |
hsa_circ_NFATC3 |
hsa_circ_0000711 |
- |
colorectal cancer |
NFATC3 |
- |
Q
| DN |
More |
| Human |
hsa_circ_NFATC3 |
hsa_circ_0005615 |
circ5615 |
colorectal cancer |
NFATC3 |
miR-149-5p, miR-331-3p |
Q
M
| UP |
More |
| Human |
hsa_circ_NFATC3 |
hsa_circ_0000711 |
- |
diabetic peripheral angiopathy |
NFATC3 |
- |
M
| DS |
More |
| Human |
hsa_circ_NFATC3 |
hsa_circ_0000711 |
circNFATC3 |
breast cancer |
NFATC3 |
hsa let7a-5p, MiR-143-3p |
Q
S
| UP |
More |
| Human |
hsa_circ_NFATC3 |
hsa_circ_0039930 |
circNFATC3 |
gastric cancer |
NFATC3 |
miR-23b-3p |
Q
H
| UP |
More |
| Human |
hsa_circ_NFATC3 |
- |
hsa_circRNA_101836 |
cerebral infarction |
NFATC3 |
hsa-miR-744-5p, hsa-miR-576-3p, hsa-miR-661, hsa-miR-9-5p, hsa-miR-377-5p |
Q
S
| DN |
More |
| Human |
hsa_circ_NFATC3 |
hsa_circ_0000711 |
circNFATC3 |
hepatocellular carcinoma |
NFATC3 |
hsa-miR-548I |
Q
| DN |
More |
| Human |
hsa_circ_NFATC3 |
hsa_circ_0005615 |
CircNFATC3 |
cervical cancer |
NFATc3 |
miR-9-5p |
Q
M
| UP |
More |
| Human |
hsa_circ_NFATC3 |
hsa_circ_0005615 |
- |
plasma cell myeloma |
NFATC3 |
- |
Q
M
| UP |
More |
| Human |
hsa_circ_NFATC3 |
hsa_circ_0000711 |
circNFATC3 / circular nuclear factor of activated T cells 3 |
gastric cancer |
NFATC3 |
- |
Q
H
| UP |
More |
| Human |
hsa_circ_NFATC3 |
hsa_circ_0005615 |
circNFATC3 |
oral cavity squamous cell carcinoma |
NFATC3 |
miR-520h |
Q
| UP |
More |
| Human |
hsa_circ_NFATC3 |
hsa_circ_0005615 |
circ_0005615 |
colorectal cancer |
- |
miR-665 |
Q
| UP |
More |
| Human |
hsa_circ_NFATC3 |
hsa_circ_0000713 |
hsa-circ-NFATC3 |
early-onset schizophrenia |
NFATC3 |
hsa-miR-370-3p |
Q
| UP |
More |
| Human |
hsa_circ_NFATC3 |
hsa_circ_0005615 |
circ_0005615 |
plasma cell myeloma |
NFATC3 |
miR-185-5p |
Q
| UP |
More |
| Human |
hsa_circ_NFATC3 |
hsa_circ_0005615 |
circ_0005615 |
colorectal cancer |
NFATC3 |
miR-873-5p |
Q
| UP |
More |
| Human |
hsa_circ_NFATC3 |
hsa_circ_0005615 |
circ_0005615 / circNFATC3 |
cervical cancer |
NFATC3 |
miR-138-5p |
Q
| UP |
More |